Chemicals

47 tickers in this theme
Ranks this page's recent reports by score.
The Mosaic Company
MOS·Materials
D ★Strong Sell
Current$22.33
Nov 6, 2026

Mosaic's globally significant phosphate and potash assets offer cyclical recovery potential, but persistent phosphate losses, negative free cash flow, and elevated leverage make the near-term investment case unattractive.

Score
51
DuPont de Nemours, Inc.
DD·Materials
B ★★★Hold
Current$145.03
Target$160.80
Return+10.9%
Nov 6, 2026

DuPont's focused specialty-materials portfolio and improving margins support sustainable earnings growth, but modest capital efficiency, legacy liabilities and an already reasonable valuation limit near-term upside.

Score
73
International Flavors & Fragrances Inc.
IFF·Materials
B ★★★Hold
Current$86.36
Target$94.32
Return+9.2%
Nov 6, 2026

IFF's specialty ingredient franchise and major portfolio divestitures could unlock stronger margins, cash flow, and shareholder returns, but weak historical capital efficiency and execution risks limit the near-term margin of safety.

Score
69
Ashland Inc.
ASH·Materials
C ★★Sell
Current$76.28
Nov 6, 2026

Ashland's specialized pharmaceutical and personal-care ingredients offer a credible earnings-recovery opportunity, but weak capital returns, persistent manufacturing inefficiencies, and a demanding valuation limit near-term investment appeal.

Score
58
The Chemours Company
CC·Materials
B ★★★Hold
Current$13.79
Target$18.27
Return+32.5%
Nov 5, 2026

Chemours offers cyclical earnings-recovery potential through titanium dioxide pricing and specialty-material growth at a historically low valuation, but high leverage and persistent PFAS obligations limit its margin of safety.

Score
67
Celanese Corporation
CE·Materials
B ★★★Hold
Current$49.75
Target$60.60
Return+21.8%
Nov 5, 2026

Celanese offers a cyclical earnings recovery and attractive normalized valuation supported by stronger cash flow, but substantial debt and volatile chemical margins constrain the investment case.

Score
68
Cabot Corporation
CBT·Materials
B ★★★Hold
Current$75.10
Target$80.63
Return+7.4%
Nov 5, 2026

Cabot combines a defensible global carbon-materials franchise with growing battery-additive opportunities at a reasonable valuation, but reinforcement pricing pressure and weaker free cash flow may constrain near-term returns.

Score
70
LyondellBasell Industries N.V.
LYB·Materials
B ★★★Hold
Current$67.25
Target$79.02
Return+17.5%
Nov 2, 2026

LyondellBasell offers cyclical earnings recovery potential through cost-advantaged polymers, improving cash flow and portfolio optimization, but global oversupply and substantial debt could delay sustained value creation.

Score
70
Sensient Technologies Corporation
SXT·Materials
C ★★Sell
Current$115.94
Nov 2, 2026

Sensient's specialty-color expertise and accelerating earnings provide long-term growth potential, but rising inventory, heavy capital expenditure, and negative free cash flow weaken the investment case.

Score
57
ExxonMobil Holdings Corporation
XOM·Energy
B ★★★Hold
Current$181.77
Target$175.00
Return-3.7%
Nov 2, 2026

ExxonMobil combines low-cost energy resources, strong cash generation, and disciplined shareholder returns, but elevated valuation and dependence on favorable commodity conditions limit near-term upside.

Score
72
Eastman Chemical Company
EMN·Materials
B ★★★Hold
Current$66.53
Target$76.80
Return+15.4%
Nov 2, 2026

Eastman's discounted specialty-materials portfolio and circular-recycling growth opportunity offer recovery potential, but elevated leverage, uneven cash conversion, and cyclical industrial demand constrain the near-term investment case.

Score
74
Olin Corporation
OLN·Materials
C ★★Sell
Current$17.60
Nov 1, 2026

Olin offers cyclical recovery potential through its integrated chemical assets, Winchester franchise, and pending Huntsman merger, but weak profitability, elevated debt, and prolonged chemical oversupply threaten shareholder returns.

Score
56